http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892769-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104892769-B |
| titleOfInvention | A kind of haemolysis plain fusion protein PeLa EK 10His SLO and its expression plasmid and application |
| abstract | The invention discloses a kind of haemolysis plain fusion protein PeLa EK 10His SLO and its expression plasmid and application, belong to medical microbial or field of biological pharmacy.Present invention haemolysis plain fusion protein PEHSLO in expression in escherichia coli, it is found that haemolysis plain fusion protein PEHSLO expression quantity improves and low to host cell toxic.Haemolysis plain fusion protein PEHSLO has pectinase activity, hemolytic and SLO antigenicities simultaneously, the engineering bacteria pectase yield is 5.6Unit/mL nutrient solutions, lysozyme yield is 400000Unit/mL, and soluble haemolysis plain fusion protein PEHSLO yields are 1.2mg/mL nutrient solutions.In production monitoring context of detection, haemolysis plain fusion protein PEHSLO can carry out qualitative and quantitative analysis with pectinase activity, avoid detecting using immunology and haemolysis method, simplify detection method, shorten detection time, saved testing cost.Haemolysis plain fusion protein PEHSLO can also be applied to hemolysin Protein S LO productions, the production of SLO antibody preparations, the production of SLO antibody tests reagent or cancer therapy drug production. |
| priorityDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.